Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.

Rochester L, Galna B, Lord S, Yarnall AJ, Morris R, Duncan G, Khoo TK, Mollenhauer B, Burn DJ.

Neurology. 2017 Apr 18;88(16):1501-1511. doi: 10.1212/WNL.0000000000003840. Epub 2017 Mar 22.

2.

Micronutrients and Risk of Parkinson's Disease: A Systematic Review.

Sherzai AZ, Tagliati M, Park K, Pezeshkian S, Sherzai D.

Gerontol Geriatr Med. 2016 Apr 22;2:2333721416644286. doi: 10.1177/2333721416644286. eCollection 2016 Jan-Dec.

3.

Iron Deposition Leads to Neuronal α-Synuclein Pathology by Inducing Autophagy Dysfunction.

Wan W, Jin L, Wang Z, Wang L, Fei G, Ye F, Pan X, Wang C, Zhong C.

Front Neurol. 2017 Jan 16;8:1. doi: 10.3389/fneur.2017.00001. eCollection 2017.

4.

Microglial activation in Parkinson's disease using [18F]-FEPPA.

Ghadery C, Koshimori Y, Coakeley S, Harris M, Rusjan P, Kim J, Houle S, Strafella AP.

J Neuroinflammation. 2017 Jan 11;14(1):8. doi: 10.1186/s12974-016-0778-1.

5.

The involvement of dityrosine crosslinking in α-synuclein assembly and deposition in Lewy Bodies in Parkinson's disease.

Al-Hilaly YK, Biasetti L, Blakeman BJ, Pollack SJ, Zibaee S, Abdul-Sada A, Thorpe JR, Xue WF, Serpell LC.

Sci Rep. 2016 Dec 16;6:39171. doi: 10.1038/srep39171.

6.

A quality improvement initiative on the management of osteoporosis in older people with Parkinsonism.

Singh I, Fletcher R, Scanlon L, Tyler M, Aithal S.

BMJ Qual Improv Rep. 2016 Oct 25;5(1). pii: u210921.w5756. eCollection 2016.

7.

Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.

Hagan S, Martin E, Enríquez-de-Salamanca A.

EPMA J. 2016 Jul 13;7:15. doi: 10.1186/s13167-016-0065-3. eCollection 2016. Review.

8.

Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders.

Lakkappa N, Krishnamurthy PT, Hammock BD, Velmurugan D, Bharath MM.

Med Hypotheses. 2016 Aug;93:161-5. doi: 10.1016/j.mehy.2016.06.003. Epub 2016 Jun 5.

PMID:
27372879
9.

Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity.

Tarale P, Chakrabarti T, Sivanesan S, Naoghare P, Bafana A, Krishnamurthi K.

Biomed Res Int. 2016;2016:2548792. doi: 10.1155/2016/2548792. Epub 2016 May 26. Review.

10.

PINK1 deficiency enhances autophagy and mitophagy induction.

Gómez-Sánchez R, Yakhine-Diop SM, Bravo-San Pedro JM, Pizarro-Estrella E, Rodríguez-Arribas M, Climent V, Martin-Cano FE, González-Soltero ME, Tandon A, Fuentes JM, González-Polo RA.

Mol Cell Oncol. 2015 Aug 20;3(2):e1046579. doi: 10.1080/23723556.2015.1046579. eCollection 2016 Mar.

11.

The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.

Benskey MJ, Perez RG, Manfredsson FP.

J Neurochem. 2016 May;137(3):331-59. doi: 10.1111/jnc.13570. Epub 2016 Mar 23. Review.

12.

Resting-state functional connectivity of the striatum in early-stage Parkinson's disease: Cognitive decline and motor symptomatology.

Manza P, Zhang S, Li CS, Leung HC.

Hum Brain Mapp. 2016 Feb;37(2):648-62. doi: 10.1002/hbm.23056. Epub 2015 Nov 14.

13.

Stem cell transplantation therapy in Parkinson's disease.

Fu MH, Li CL, Lin HL, Chen PC, Calkins MJ, Chang YF, Cheng PH, Yang SH.

Springerplus. 2015 Oct 13;4:597. doi: 10.1186/s40064-015-1400-1. eCollection 2015. Review.

14.

Mitochondria: A Therapeutic Target for Parkinson's Disease?

Luo Y, Hoffer A, Hoffer B, Qi X.

Int J Mol Sci. 2015 Sep 1;16(9):20704-30. doi: 10.3390/ijms160920704. Review.

15.

Younger age at onset of sporadic Parkinson's disease among subjects occupationally exposed to metals and pesticides.

Ratner MH, Farb DH, Ozer J, Feldman RG, Durso R.

Interdiscip Toxicol. 2014 Sep;7(3):123-33. doi: 10.2478/intox-2014-0017. Epub 2014 Dec 30.

16.

Comparison of frequencies of non motor symptoms in Indian Parkinson's disease patients on medical management versus deep brain stimulation: A case-control study.

Rukmini Mridula K, Borgohain R, Jabeen SA, Padmaja G, Bandaru VS, Ankathi P, Kanikannan MA, Ali Khan MS.

Iran J Neurol. 2015 Apr 4;14(2):86-93.

17.

Recent progress of imaging agents for Parkinson's disease.

Wu X, Cai H, Ge R, Li L, Jia Z.

Curr Neuropharmacol. 2014 Dec;12(6):551-63. doi: 10.2174/1570159X13666141204221238.

18.

Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases.

Chin-Chan M, Navarro-Yepes J, Quintanilla-Vega B.

Front Cell Neurosci. 2015 Apr 10;9:124. doi: 10.3389/fncel.2015.00124. eCollection 2015. Review.

19.

Bursting activity of substantia nigra pars reticulata neurons in mouse parkinsonism in awake and anesthetized states.

Lobb CJ, Jaeger D.

Neurobiol Dis. 2015 Mar;75:177-85. doi: 10.1016/j.nbd.2014.12.026. Epub 2015 Jan 6.

20.

A study on risk factors for Parkinson׳s disease in Indian population.

Gupta V, Garg RK, Pant KK, Khattri S.

Bioinformation. 2014 Jun 30;10(6):342-6. doi: 10.6026/97320630010342. eCollection 2014.

Supplemental Content

Support Center